{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:14:56Z","timestamp":1740107696028,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10067-023-06581-0","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T17:02:52Z","timestamp":1680022972000},"page":"1479-1483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["How are rheumatologists from Argentina managing patients with arthralgias suspicious for progressing to rheumatoid arthritis?"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-0023","authenticated-orcid":false,"given":"Juan Pablo","family":"Vinicki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8386-8937","authenticated-orcid":false,"given":"Jos\u00e9 Luis Velasco","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-1092","authenticated-orcid":false,"given":"Rodrigo Garc\u00eda","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-9175","authenticated-orcid":false,"given":"Graciela S.","family":"Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"6581_CR1","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","volume":"370","author":"JS Smolen","year":"2007","unstructured":"Smolen JS, Aletaha D, Koeller M et al (2007) New therapies for the treatment of rheumatoid arthritis. Lancet 370:1861\u20131874","journal-title":"Lancet"},{"key":"6581_CR2","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/ard.2008.094151","volume":"68","author":"VP van Halm","year":"2009","unstructured":"van Halm VP, Peters MJL, Voskuyl AE et al (2009) Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 68:1395\u20131400","journal-title":"Ann Rheum Dis"},{"key":"6581_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/ard.2010.143396","volume":"70","author":"J Lindhardsen","year":"2011","unstructured":"Lindhardsen J, Ahlehoff O, Gislason GH et al (2011) The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 70:929\u2013934","journal-title":"Ann Rheum Dis"},{"key":"6581_CR4","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","volume":"336","author":"J Hippisley-Cox","year":"2008","unstructured":"Hippisley-Cox J, Coupland C, Vinogradova Y et al (2008) Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 336:1475\u20131482","journal-title":"BMJ"},{"key":"6581_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis 76:17\u201328","journal-title":"Ann Rheum Dis"},{"key":"6581_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/annrheumdis-2016-209846","volume":"76","author":"HW van Steenbergen","year":"2017","unstructured":"van Steenbergen HW, Aletaha D, Beaart-van de Voorde LJ et al (2017) EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Ann Rheum Dis 76:491\u2013496","journal-title":"Ann Rheum Dis"},{"key":"6581_CR7","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1093\/rheumatology\/kex324","volume":"56","author":"LE Burgers","year":"2017","unstructured":"Burgers LE, Siljehult F, Ten Brinck RM et al (2017) Validation of the EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Rheumatology (Oxford) 56:2123\u20132128","journal-title":"Rheumatology (Oxford)"},{"key":"6581_CR8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s10067-019-04855-0","volume":"39","author":"S Ruta","year":"2020","unstructured":"Ruta S, Prado ES, Chichande JT et al (2020) EULAR definition of \u201carthralgia suspicious for progression to rheumatoid arthritis\u201d in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound. Clin Rheumatol 39:1493\u20131499","journal-title":"Clin Rheumatol"},{"issue":"5","key":"6581_CR9","doi-asserted-by":"publisher","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","volume":"7","author":"J Sokolove","year":"2012","unstructured":"Sokolove J, Bromberg R, Deane KD et al (2012) Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 7(5):e35296","journal-title":"PLoS One"},{"key":"6581_CR10","unstructured":"National Audit Office (NAO). Services for people with rheumatoid arthritis, 2009. https:\/\/www.nao.org.uk\/wp-content\/uploads\/2009\/07\/0809823.pdf. Accessed November 20, 2022."},{"key":"6581_CR11","unstructured":"Reuma \u00bfqui\u00e9n sos?, Portal informativo sobre reumatolog\u00eda, 2011. https:\/\/www.reumaquiensos.org.ar\/. Accessed November 20, 2022."},{"key":"6581_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380\u2013386","journal-title":"Arthritis Rheum"},{"key":"6581_CR13","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S, de Jong BA, Berglin E et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741\u20132749","journal-title":"Arthritis Rheum"},{"key":"6581_CR14","doi-asserted-by":"publisher","first-page":"R303","DOI":"10.1186\/ar1187","volume":"6","author":"E Berglin","year":"2004","unstructured":"Berglin E, Padyukov L, Sundin U et al (2004) A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 6:R303\u2013R308","journal-title":"Arthritis Res Ther"},{"key":"6581_CR15","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1136\/annrheumdis-2012-202254","volume":"72","author":"MJ de Hair","year":"2013","unstructured":"de Hair MJ, Landew\u00e9 RB, van de Sande MG et al (2013) Smoking and overweight determine the likelihood of developing rheumatoid arthritis. Ann Rheum Dis 72:1654\u20131658","journal-title":"Ann Rheum Dis"},{"key":"6581_CR16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","volume":"62","author":"H Kokkonen","year":"2010","unstructured":"Kokkonen H, S\u00f6derstr\u00f6m I, Rockl\u00f6v J et al (2010) Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 62:383\u2013391","journal-title":"Arthritis Rheum"},{"key":"6581_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/annrheumdis-2012-203158","volume":"72","author":"AN Colebatch","year":"2013","unstructured":"Colebatch AN, Edwards CJ, \u00d8stergaard M et al (2013) EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 72:804\u2013814","journal-title":"Ann Rheum Dis"},{"key":"6581_CR18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/ard.2008.105759","volume":"69","author":"WH Bos","year":"2010","unstructured":"Bos WH, Wolbink GJ, Boers M et al (2010) Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis 69:490\u2013494","journal-title":"Ann Rheum Dis"},{"key":"6581_CR19","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1136\/annrheumdis-2014-205227","volume":"74","author":"C Rakieh","year":"2015","unstructured":"Rakieh C, Nam JL, Hunt L et al (2015) Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Ann Rheum Dis 74:1659\u20131666","journal-title":"Ann Rheum Dis"},{"key":"6581_CR20","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1136\/annrheumdis-2012-202127","volume":"72","author":"LA van de Stadt","year":"2013","unstructured":"van de Stadt LA, Witte BI, Bos WH et al (2013) A prediction rule for the development of arthritis in seropositive arthralgia patients. Ann Rheum Dis 72:1920\u20131926","journal-title":"Ann Rheum Dis"},{"key":"6581_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","volume":"78","author":"DM Gerlag","year":"2019","unstructured":"Gerlag DM, Safy M, Maijer KI, Tang MW et al (2019) Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study. Ann Rheum Dis 78:179\u2013185","journal-title":"Ann Rheum Dis"},{"key":"6581_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","volume":"400","author":"DI Krijbolder","year":"2022","unstructured":"Krijbolder DI, Verstappen M, van Dijk BT (2022) Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet 400:283\u2013294","journal-title":"Lancet"},{"key":"6581_CR23","unstructured":"Deane K, Striebich C, Feser M et al (2022) Hydroxychloroquine does not prevent the future development of rheumatoid arthritis in a population with baseline high levels of antibodies to citrullinated protein antigens and absence of inflammatory arthritis: interim analysis of the StopRA Trial. Arthritis Rheumatol 74(suppl 9)"},{"key":"6581_CR24","unstructured":"Rech J, Kleyer A, \u00d8stergaard M et al (2022) Abatacept significantly reduces subclinical inflammation during treatment (6 months), this persists after discontinuation (12 months), resulting in a delay in the clinical development of RA in patients at risk of RA (the ARIAA study). Arthritis Rheumatol 74(suppl 9)"},{"issue":"20","key":"6581_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13063-019-3403-7","volume":"15","author":"M Al-Laith","year":"2019","unstructured":"Al-Laith M, Jasenecova M, Abraham S et al (2019) Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials 15(20):429","journal-title":"Trials"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06581-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T20:32:43Z","timestamp":1702153963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06581-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6581"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06581-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"5 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}